SeaCrest Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SeaCrest Wealth Management's ARKG Position: Q3 2022 in Review
SeaCrest Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 11,036 shares — an estimated $348K sold.
SeaCrest Wealth Management first reported a position in ARKG in Q2 2018 and held it in 17 quarters. The position peaked at $1.17M in Q2 2019. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.
- SeaCrest Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
- SeaCrest Wealth Management sold 11,036 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $348K.
- SeaCrest Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 17 quarters.
- SeaCrest Wealth Management's ARK Genomic Revolution ETF position peaked at $1.17M in Q2 2019.
- 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.
Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.